Padlock Therapeutics researches, discovers, develops and commercializes drugs for protein arginine deiminases.
Business Model:
Revenue: $1M
Employees: 11-50
Padlock Therapeutics was acquired by
Bristol Myers Squibb.
The acquisition happend on 2016-03-23.
Details of the transaction were not public
Address: 200 Cambridgepark Dr
City: Cambridge
State: MA
Zip: 02140
Country: US
Padlock Therapeutics researches, discovers, develops and commercializes drugs for protein arginine deiminases.
Contact Phone:
+19783819601
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2014 | Series A | 4 | $23M |
Edward Kliphuis Atlas Venture Index Ventures Johnson &a; Johnson Development Corporation Atlas Venture Edward Kliphuis Atlas Venture Index Ventures Johnson &a; Johnson Development Corporation Atlas Venture |
4/2014 | Series A | 1 | $14.7M |
M Ventures M Ventures M Ventures M Ventures |
4/2014 | Series A | 1 | $14.7M |
M Ventures M Ventures M Ventures M Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|